Detalles de la búsqueda
1.
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients.
Int J Cancer
; 153(6): 1217-1226, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243480
2.
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
Br J Cancer
; 128(7): 1286-1293, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717671
3.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 266-274, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396818
4.
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.
Oncologist
; 28(9): e703-e711, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36940301
5.
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
Oncologist
; 28(12): e1179-e1184, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699107
6.
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort.
Int J Cancer
; 151(8): 1355-1366, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35666525
7.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152285
8.
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Oncologist
; 25(9): e1355-e1362, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32618068
9.
Olaparib for advanced breast cancer.
Future Oncol
; 16(12): 717-732, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32249603
10.
Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
Breast J
; 26(7): 1296-1301, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31837103
11.
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies.
Int J Mol Sci
; 21(21)2020 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33143050
12.
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value.
Oncologist
; 24(11): e1055-e1069, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31444294
13.
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Oncologist
; 24(11): 1424-1431, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152079
14.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31747948
15.
Immune characterization of breast cancer metastases: prognostic implications.
Breast Cancer Res
; 20(1): 62, 2018 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29929548
16.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Br J Cancer
; 128(2): 398, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460777
17.
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Oncologist
; 23(11): 1289-1299, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120164
18.
First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.
Oncologist
; 23(3): 297-305, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133514
19.
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
J Neurooncol
; 138(2): 369-382, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29488184
20.
Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
J Neurooncol
; 131(2): 369-376, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853958